News

WHO Summit Confirms Global Approach COVID-19

- Op de jaarvergadering van de Wereldgezondheidsorganisatie WHO hebben meer dan 130 landen een resolutie aangenomen om gezamenlijk de wereldwijde coronapandemie te bestrijden.

The CE Tool as a Convenient Check for the MDR

- Door de COVID-19 pandemie is de introductie van de nieuwe wetgeving voor medische hulpmiddelen in Europa, de Medical Device Regulation (MDR), een jaar uitgesteld. Hierdoor heeft u een jaar langer de tijd om uw certificering van uw product of software op orde te krijgen. U kunt deze tijd gebruiken om u goed voor te bereiden en te laten adviseren waar dat nodig is.

First Clinical Trial with Genetically Modified Malaria Vaccine Completed

- In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.

Project recovery during the COVID-19 crisis

- The outbreak of COVID-19 and the measures taken against it have raided us all. The closure of many laboratories, the (temporary) termination of clinical research, etcetera can have effects on, among other things, the execution, duration and financing of the research. This situation requires flexibility and creativity. Top Sector Life Sciences & Health (Health~Holland) feels a joint responsibility for finding solutions to ensure good progress and completion of all studies.

Namens Nederland Opens Idea Platform for Young People Who Want to Tackle Rutte's Challenge

- Het platform Namens Nederland (www.idee.namensnederland.nl) gaat inzichten en ideeën verzamelen van kinderen en jongeren die de uitdaging van premier Rutte willen aangaan. Tijdens zijn persconferentie riep de premier jongeren op om niet af te wachten, maar actief bij te dragen aan het oplossen van de coronacrisis.

Results: Impact of COVID-19 on Life Sciences Industry

- This month ttopstart has interviewed 50 European life sciences companies on how they are impacted by and have responded to the COVID-19 crisis. In the report the results are discussed and translated into recommendations.

Three More Projects Awarded in COVID-19 Call

- COVID-19 was officially declared a pandemic on 11 March 2020. To prevent the disease from spreading, research projects have been set up at a rapid pace. Top Sector Life Sciences & Health has taken quick action to set up a COVID-19 call at the end of March. Three more projects have been awarded and are granted PPP Allowance to start their research.

Second Coronavirus Call for an Expression of Interest

- This second call for an expression of interest complements the first expression of interest that the European Commission published in January 2020, which led to the funding of 18 projects in March 2020. The first expression of interest focused on advancing the knowledge on SARS-CoV-2 and its impact on infected persons, with the aim of contributing to an efficient patient management and/or public health preparedness and response.

Mymetics and Baylor College of Medicine Start Research Collaboration Virosome-based COVID19 Vaccines

- Mymetics, a pioneer and leader in the research and development of virosome-based vaccines against life threatening and life disabling diseases, has signed a Research Collaboration Agreement with Baylor College of Medicine and Texas Children’s Center for Vaccine Development. They will be evaluating their rationally designed recombinant protein-based SARS-CoV and SARS-CoV-2 antigens and combining them with Mymetics’ virosomes for the development of a safe and effective Covid-19 vaccine.

Leiden Joins Forces to Develop Improved Vaccines for Coronaviruses

- De publieke-private samenwerking tussen het Leids Universitair Medisch Centrum (LUMC) en twee Leidse bedrijven, ISA Therapeutics en Immunetune, heeft 724.000 euro ontvangen van Topsector Life Sciences & Health (;Health~Holland). Het geld zal gebruikt worden om vaccins tegen het huidige coronavirus en andere coronavirussen te ontwikkelen.